Glucosamine in a Cushing’s Horse?
Emily Graves, VMD, MS, Dipl. ACVIM
December 1, 2008
As soon as my 20-year-old gelding was diagnosed with equine Cushing’s disease, I eliminated glucosamine from his diet.
Information on pituitary pars intermedia dysfunction (PPID), also known as Cushing’s Disease in horses.
As soon as my 20-year-old gelding was diagnosed with equine Cushing’s disease, I eliminated glucosamine from his diet.
Elanco Animal Health (a division of Eli Lilly and Company), in collaboration with Michigan State University, Oklahoma State University, and Louisiana State University, is seeking horses with equine Cushing’s disease, also known as pituitary pars
Owners of older horses that exhibit any of the classic signs of Cushing’s during the fall months work with their veterinarians to determine whether they should test or treat horses until diagnoses can be confirmed.
Research groups reported their findings of the impact of seasonal variations for pituitary glad dysfunction.
Dianne McFarlane, DVM, PhD, Dipl. ACVIM, Dipl. ABVP, is an assistant professor with the Oklahoma State University (OSU) Center for Veterinary Health Sciences. McFarlane recently received a grant from the National Institutes of Health (NIH) to
Wedgewood Pharmacy has introduced peppermint- and alfalfa-flavored pergolide for horses in its Gourmeds dosage form. Gourmeds are chewable, naturally flavored tablets that are easy to administer.
Pergolide mesylate, a drug used to treat
When it comes to horses, what does “low carb” mean? Lower than what? “There are several analytical procedures that measure sugar, and each one measures a slightly different fraction,” said Kathryn Watts, BS, owner of Rocky Mountain Research & Consult
Horses suffer from few endocrine disorders compared to humans and companion animals; however, they’re not totally off the hook, explained Emily Graves, VMD, MS, Dipl. ACVIM, of Michigan State University, to horse owners in attendance at the
The lack of dopamine is critical, as the activity of the pars intermedia is normally inhibited (controlled) by dopamine. Without dopamine, the pars intermedia produces much more hormone than it should, causing the clinical signs of PPID.
Medication options for PPID include pergolide, cyproheptadine, trilostane, and chasteberry extract. One disadvantage is that no treatment is currently FDA-approved for PPID in horses.
Pituitary pars intermedia dysfunction–PPID, or Cushing’s disease–is the most common disease of horses and ponies 15 years of age or older. Although it’s not fully understood yet, researchers are learning more about how to treat and prevent it.
Unfortunately, no perfect PPID test (one that is 100% accurate with a single-sample test) yet exists. At the 2006 AAEP Convention, Harold Schott, DVM, PhD, Dipl. ACVIM, professor of large animal clinical sciences at Michigan State University,
We know Cushing’s disease (or pituitary pars intermedia dysfunction?PPID?as it’s more scientifically called), simply put, is an “old-horse disease” that results in metabolism disturbances and an abnormally heavy hair coat. But when it comes to
The Food and Drug Administration’s (FDA) Center for Veterinary Medicine announced on May 11 it will allow bulk pergolide to be used in compounding pergolide for use in horses.
Pergolide mesylate, a drug commonly used to treat pituitar
More than a month after pergolide mesylate, a drug commonly used to treat pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease, was withdrawn for human use, the FDA has yet to make an announcement on whether
Pergolide mesylate, a drug commonly used to treat pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease, has been withdrawn for human use. The FDA made this announcement March 29. Since that time, horse owners and
Stay on top of the most recent Horse Health news with
